28149283|t|Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity.
28149283|a|Recent studies have linked changes in peripheral chemokine concentrations to the presence of both addictive behaviors and psychiatric disorders. The present study further explore this link by analyzing the potential association of psychiatry comorbidity with alterations in the concentrations of circulating plasma chemokine in patients of both sexes diagnosed with alcohol use disorders (AUD). To this end, 85 abstinent subjects with AUD from an outpatient setting and 55 healthy subjects were evaluated for substance and mental disorders. Plasma samples were obtained to quantify chemokine concentrations [C-C motif (CC), C-X-C motif (CXC), and C-X3-C motif (CX3C) chemokines]. Abstinent AUD patients displayed a high prevalence of comorbid mental disorders (72%) and other substance use disorders (45%). Plasma concentrations of chemokines CXCL12/stromal cell-derived factor-1 (p < 0.001) and CX3CL1/fractalkine (p < 0.05) were lower in AUD patients compared to controls, whereas CCL11/eotaxin-1 concentrations were strongly decreased in female AUD patients (p < 0.001). In the alcohol group, CXCL8 concentrations were increased in patients with liver and pancreas diseases and there was a significant correlation to aspartate transaminase (r = +0.456, p < 0.001) and gamma-glutamyltransferase (r = +0.647, p < 0.001). Focusing on comorbid psychiatric disorders, we distinguish between patients with additional mental disorders (N = 61) and other substance use disorders (N = 38). Only CCL11 concentrations were found to be altered in AUD patients diagnosed with mental disorders (p < 0.01) with a strong main effect of sex. Thus, patients with mood disorders (N = 42) and/or anxiety (N = 16) had lower CCL11 concentrations than non-comorbid patients being more evident in women. The alcohol-induced alterations in circulating chemokines were also explored in preclinical models of alcohol use with male Wistar rats. Rats exposed to repeated ethanol (3 g/kg, gavage) had lower CXCL12 (p < 0.01) concentrations and higher CCL11 concentrations (p < 0.001) relative to vehicle-treated rats. Additionally, the increased CCL11 concentrations in rats exposed to ethanol were enhanced by the prior exposure to restraint stress (p < 0.01). Concordantly, acute ethanol exposure induced changes in CXCL12, CX3CL1, and CCL11 in the same direction to repeated exposure. These results clearly indicate a contribution of specific chemokines to the phenotype of AUD and a strong effect of sex, revealing a link of CCL11 to alcohol and anxiety/stress.
28149283	21	29	Patients	Species	9606
28149283	35	56	Alcohol Use Disorders	Disease	MESH:D000437
28149283	73	78	CCL11	Gene	6356
28149283	80	89	Eotaxin-1	Gene	6356
28149283	96	119	Psychiatric Comorbidity	Disease	MESH:D001523
28149283	219	238	addictive behaviors	Disease	MESH:D000437
28149283	243	264	psychiatric disorders	Disease	MESH:D001523
28149283	449	457	patients	Species	9606
28149283	487	508	alcohol use disorders	Disease	MESH:D000437
28149283	510	513	AUD	Disease	MESH:D000437
28149283	556	559	AUD	Disease	MESH:D000437
28149283	568	578	outpatient	Species	9606
28149283	630	639	substance	Disease	MESH:D019966
28149283	644	660	mental disorders	Disease	MESH:D001523
28149283	811	814	AUD	Disease	MESH:D000437
28149283	815	823	patients	Species	9606
28149283	864	880	mental disorders	Disease	MESH:D001523
28149283	897	920	substance use disorders	Disease	MESH:D019966
28149283	964	970	CXCL12	Gene	6387
28149283	971	1000	stromal cell-derived factor-1	Gene	6387
28149283	1017	1023	CX3CL1	Gene	6376
28149283	1024	1035	fractalkine	Gene	6376
28149283	1061	1064	AUD	Disease	MESH:D000437
28149283	1065	1073	patients	Species	9606
28149283	1104	1109	CCL11	Gene	6356
28149283	1110	1119	eotaxin-1	Gene	6356
28149283	1169	1172	AUD	Disease	MESH:D000437
28149283	1173	1181	patients	Species	9606
28149283	1202	1209	alcohol	Chemical	MESH:D000438
28149283	1217	1222	CXCL8	Gene	3576
28149283	1256	1264	patients	Species	9606
28149283	1270	1297	liver and pancreas diseases	Disease	MESH:D008107
28149283	1392	1417	gamma-glutamyltransferase	Gene	2678
28149283	1464	1485	psychiatric disorders	Disease	MESH:D001523
28149283	1510	1518	patients	Species	9606
28149283	1535	1551	mental disorders	Disease	MESH:D001523
28149283	1571	1594	substance use disorders	Disease	MESH:D019966
28149283	1610	1615	CCL11	Gene	6356
28149283	1659	1662	AUD	Disease	MESH:D000437
28149283	1663	1671	patients	Species	9606
28149283	1687	1703	mental disorders	Disease	MESH:D001523
28149283	1755	1763	patients	Species	9606
28149283	1769	1783	mood disorders	Disease	MESH:D019964
28149283	1800	1807	anxiety	Disease	MESH:D001007
28149283	1827	1832	CCL11	Gene	6356
28149283	1866	1874	patients	Species	9606
28149283	1897	1902	women	Species	9606
28149283	1908	1915	alcohol	Chemical	MESH:D000438
28149283	2006	2013	alcohol	Chemical	MESH:D000438
28149283	2035	2039	rats	Species	10116
28149283	2041	2045	Rats	Species	10116
28149283	2066	2073	ethanol	Chemical	MESH:D000431
28149283	2101	2107	CXCL12	Gene	6387
28149283	2145	2150	CCL11	Gene	6356
28149283	2206	2210	rats	Species	10116
28149283	2240	2245	CCL11	Gene	6356
28149283	2264	2268	rats	Species	10116
28149283	2280	2287	ethanol	Chemical	MESH:D000431
28149283	2376	2383	ethanol	Chemical	MESH:D000431
28149283	2412	2418	CXCL12	Gene	6387
28149283	2420	2426	CX3CL1	Gene	6376
28149283	2432	2437	CCL11	Gene	6356
28149283	2571	2574	AUD	Disease	MESH:D000437
28149283	2623	2628	CCL11	Gene	6356
28149283	2632	2639	alcohol	Chemical	MESH:D000438
28149283	2644	2651	anxiety	Disease	MESH:D001007
28149283	Negative_Correlation	MESH:D000437	6356
28149283	Association	MESH:D019964	6356
28149283	Association	MESH:D000437	6376
28149283	Association	2678	3576
28149283	Association	MESH:D000438	MESH:D008107
28149283	Negative_Correlation	MESH:D000437	6387
28149283	Association	MESH:D001523	6356
28149283	Association	MESH:D008107	3576
28149283	Negative_Correlation	MESH:D000431	6387
28149283	Association	MESH:D001007	6356

